JAK2 and precursor B-cell acute lymphoblastic leukemia: These B-ALL patients are most often male, present with hyperleukocytosis, respond poorly to chemotherapy, often relapse, and tend to have little to no cytogenetic abnormalities apart from those involving JAK2[1].